Addressing Evolving Educational Needs on BTK Inhibitor Therapies in CLL/SLL and MCL

Hear expert faculty discuss areas of consensus and controversies on the use of approved and emerging BTK inhibitors in managing CLL and MCL. Review their insights in an on-demand webcast adapted from a live webinar downloadable slideset 2 commentaries and a podcast.

Share

Program Content

Activities

BTKi Therapies
Addressing Evolving Educational Needs on BTK Inhibitor Therapies in CLL/SLL and MCL
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2022

Expires: April 03, 2023

Activities

Managing MCL with BTKis
How I Manage Mantle Cell Lymphoma Using BTK Inhibitors: A Case Study From My Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 07, 2022

Expires: March 06, 2023

CLL: HCP Needs
CLL Treatment: Cutting Though the Noise to Address Educational Needs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 25, 2022

Expires: April 24, 2023

Activities

BTKi FAQ
Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 31, 2022

Expires: March 30, 2023

<i>Pearls</i>: BTKi FAQ
Podcast Pearls: Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: April 14, 2022

Expires: April 13, 2023

Activities

BTKi for CLL and MCL
BTK Inhibitor Therapies in CLL/SLL and MCL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2022

Expires: March 10, 2023

<i>EP</i>: BTKi for CLL and MCL
ExpressPoints: BTK Inhibitor Therapies in CLL/SLL and MCL
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2022

Expires: March 10, 2023

Faculty

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Matthew S. Davids, MD, MMSc

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research
Division of Lymphoma
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Christopher R. Flowers, MD, MS

Department Chair
Department of Lymphoma/Myeloma, Division of Cancer Medicine
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Lilly